FDA-Drug2026-04-15Class IIPROCESSING DEFECT

Fresenius Kabi sodium chloride injection recalled for sterility assurance

OTHERNationwide distributionDrugs

What this means

Fresenius Kabi USA is recalling multiple batches of 0.9% Sodium Chloride Injection (saline solution) used for medical purposes because the manufacturer cannot guarantee the product is sterile. The affected batches were distributed nationwide, Alaska, and Puerto Rico. No injuries have been reported.

  • Check if you have any Fresenius Kabi 0.9% Sodium Chloride Injection 250 mL freeflex bags with batch numbers and expiration dates matching the recall list
  • Do not use recalled batches; return them to your pharmacy or healthcare provider immediately
  • Contact your doctor or pharmacist if you have already used product from a recalled batch
The agency's original wording
Hazard

Lack of Assurance of Sterility

Intended for
All ages
Illnesses reported
None reported
Sold states
US Nationwide , Alaska, and Puerto Rico.
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Products
0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-470-05, Unit of Sale NDC Number: 65219-470-30.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0427-2026

More Fresenius Kabi recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime